Editor-in-Chief

Daniel Scherman
Laboratory of Chemical and Biological Technology for Health, Pharmacy Faculty, Paris University, Paris, France.
Fondation Maladies Rares - Foundation for Rare Diseases, Paris, France.
HomePage
Research Interests
Bioenergetics, neuropharmacology and neurodegenerative diseases, gene therapy, the quantification of dopaminergic neuronal death in Parkinson's disease
Contributions:

RNA antisense and silencing strategies using synthetic drugs for rare muscular and neuromuscular diseases

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/